{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T16:58:35Z","timestamp":1784566715771,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Anorexia nervosa (AN) is a serious and potentially life-threatening eating disorder characterized by starvation and malnutrition, a high prevalence of coexisting psychiatric conditions, marked treatment resistance, frequent medical complications, and a substantial risk of death. Body mass index (BMI) is a key measure of treatment outcome of AN and it is necessary to evaluate the long-term prognosis of AN. This study aimed to better assess the BMI course trend between different medications and timepoints in order to improve\u00a0AN treatment in clinical practice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>During the period 2010\u20132021, we retrospectively reviewed historical data of all patients diagnosed with AN. There were two groups in this study, which were based on the duration of follow-up. Group A was a 6-month follow-up group, comprising 93 patients (mean age 19.6\u2009\u00b1\u20096.8\u00a0years), with BMI assessed at three consecutive time points: first outpatient visit (T0), three months follow-up (T3), and six months follow-up (T6). Group B was a 12-month follow-up group comprising 36 patients (mean age 17.0\u2009\u00b1\u20095.2\u00a0years) with BMI assessed at five consecutive time points: first outpatient visit (T0), three months follow-up (T3), six months follow-up (T6), nine months follow-up (T9), and twelve months follow-up (T12). In our study, we retrospectively compared BMI courses based on patients\u2019 usage of medication using the following variables: single medication, switching medications, combined medications, and without medications. The primary outcome measurement was BMI recorded at the 6-month follow-up and the 12-month follow-up respectively. In our study, which was conducted at Taichung Veterans General Hospital, we reviewed outpatient medical records of all patients with AN who were seen at the hospital during the period 2010\u20132021.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In Group A (6-month follow-up), patients treated with antidepressants showed a mean BMI increase of 1.3 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001); patients treated with antipsychotics showed a mean BMI increase of 1.1 (<jats:italic>p<\/jats:italic>\u2009=\u20090.01); patients treated with switching medications showed a mean BMI increase of 0.1 (<jats:italic>p<\/jats:italic>\u2009=\u20090.397); patients treated with combined medications showed a mean BMI increase of 0.5 (<jats:italic>p<\/jats:italic>\u2009=\u20090.208); and patients treated without medications showed a mean BMI increase of 0.1 (<jats:italic>p<\/jats:italic>\u2009=\u20090.821). The results indicated that patients with AN had a significant BMI increase after treatment with antidepressants and antipsychotics in the 6-month follow-up group. In Group B (12-month follow-up), patients treated with antidepressants showed a mean BMI increase of 2.7 (<jats:italic>p\u2009<\/jats:italic>&lt;\u20090.001); patients treated with antipsychotics showed a mean BMI increase of 2.8 (<jats:italic>p<\/jats:italic>\u2009=\u20090.168); patients treated with switching medications showed a mean BMI decrease of 0.8 (<jats:italic>p<\/jats:italic>\u2009=\u20090.595); patients treated with combined medications showed a mean BMI increase of 1.6 (<jats:italic>p<\/jats:italic>\u2009=\u20090.368); and patients treated without medications showed a mean BMI increase of 1.0 (<jats:italic>p<\/jats:italic>\u2009=\u20090.262). The results indicated that patients with AN had a significant BMI increase after treatment with antidepressants at the 12-month follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>AN is a complex disease caused by multiple factors. Evaluating its long-term prognosis is crucial. Our study provides insights and highlights three key findings: 1) medication adherence is crucial in treating AN, 2) frequent switching of medications may not promote weight gain and may also require a re-establishment of rapport with patients with AN, and 3) pharmacotherapy, especially antidepressants, is more effective than no treatment. Further research is needed to confirm these findings.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12888-023-04604-3","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T14:03:02Z","timestamp":1677506582000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A retrospective study of pharmacological treatment in anorexia nervosa: 6-month and 12-month follow-up"],"prefix":"10.1186","volume":"23","author":[{"given":"Huei-Ping","family":"Chiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shr-Yu","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiann-Yi","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,27]]},"reference":[{"key":"4604_CR1","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJMcp1803175","volume":"382","author":"CG Solomon","year":"2020","unstructured":"Solomon CG, MitchellPeterson JECB. Anorexia nervosa. N Engl J Med. 2020;382:1343\u201351.","journal-title":"N Engl J Med"},{"key":"4604_CR2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Publishing; 2013.","edition":"5"},{"key":"4604_CR3","volume-title":"Anorexia nervosa","author":"CA Moore","year":"2021","unstructured":"Moore CA, Bokor BR. Anorexia nervosa. In StatPearls: Stat- Pearls Publishing; 2021."},{"issue":"2","key":"4604_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1176\/appi.ajp.2007.07060951","volume":"165","author":"KT Eddy","year":"2008","unstructured":"Eddy KT, Dorer DJ, Franko DL, Tahilani K, Thompson-Brenner H, Herzog DB. Diagnostic crossover in anorexia nervosa and bulimia nervosa: implications for DSM-V. Am J Psychiatry. 2008;165(2):245\u201350.","journal-title":"Am J Psychiatry"},{"issue":"7","key":"4604_CR5","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/eat.20717","volume":"42","author":"C Peat","year":"2009","unstructured":"Peat C, Mitchell JE, Hoek HW, Wonderlich SA. Validity and utility of subtyping anorexia nervosa. Int J Eat Disord. 2009;42(7):590\u20134.","journal-title":"Int J Eat Disord"},{"key":"4604_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.eatbeh.2017.12.004","volume":"28","author":"DL Reas","year":"2018","unstructured":"Reas DL, R\u00f8 \u00d8. Less symptomatic, but equally impaired: Clinical impairment in restricting versus binge-eating\/purging subtype of anorexia nervosa. Eat Behav. 2018;28:32\u20137.","journal-title":"Eat Behav"},{"key":"4604_CR7","doi-asserted-by":"crossref","unstructured":"Serra R, Di Nicolantonio C, Di Febo R, De Crescenzo F, Vanderlinden J, Vrieze E, Tarsitani L. The transition from restrictive anorexia nervosa to binging and purging: a systematic review and meta-analysis. Eating and Weight Disorders-Studies on Anorexia, Bulimia and Obesity. 2022:27(3):857-65.","DOI":"10.1007\/s40519-021-01226-0"},{"issue":"1","key":"4604_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s40519-015-0211-2","volume":"21","author":"L Errichiello","year":"2016","unstructured":"Errichiello L, Iodice D, Bruzzese D, Gherghi M, Senatore I. Prognostic factors and outcome in anorexia nervosa: a follow-up study. Eat Weight Disord-Stud Anorexia, Bulimia Obesity. 2016;21(1):73\u201382.","journal-title":"Eat Weight Disord-Stud Anorexia, Bulimia Obesity"},{"issue":"9205","key":"4604_CR9","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0140-6736(99)05363-5","volume":"355","author":"S Zipfel","year":"2000","unstructured":"Zipfel S, L\u00f6we B, Reas DL, Deter H-C, Herzog W. Long-term prognosis in anorexia nervosa: lessons from a 21-year follow-up study. The Lancet. 2000;355(9205):721\u20132.","journal-title":"The Lancet"},{"key":"4604_CR10","doi-asserted-by":"publisher","first-page":"682952","DOI":"10.3389\/fpsyt.2021.682952","volume":"12","author":"L-K Kaufmann","year":"2021","unstructured":"Kaufmann L-K, Moergeli H, Milos GF. Lifetime weight characteristics of adult inpatients with severe anorexia nervosa: maximal lifetime BMI predicts treatment outcome. Front Psychiatry. 2021;12:682952.","journal-title":"Front Psychiatry"},{"issue":"2","key":"4604_CR11","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3390\/jcm8020278","volume":"8","author":"C Blanchet","year":"2019","unstructured":"Blanchet C, Guillaume S, Bat-Pitault F, Carles M-E, Clarke J, Dodin V, Iceta S. Medication in AN: a multidisciplinary overview of meta-analyses and systematic reviews. J Clin Med. 2019;8(2):278.","journal-title":"J Clin Med"},{"key":"4604_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.psychres.2016.07.002","volume":"244","author":"B Wild","year":"2016","unstructured":"Wild B, Friederich H-C, Zipfel S, Resmark G, Giel K, Teufel M, Zeeck A. Predictors of outcomes in outpatients with anorexia nervosa\u2013Results from the ANTOP study. Psychiatry Res. 2016;244:45\u201350.","journal-title":"Psychiatry Res"},{"key":"4604_CR13","unstructured":"National Institute for Health and Care Excellence. Eating disorders: recognition and treatment: NICE guideline, No. 69. 2017. https:\/\/www.nice.org.uk\/guidance\/ng69."},{"issue":"2","key":"4604_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/jcm8020153","volume":"8","author":"G Resmark","year":"2019","unstructured":"Resmark G, Herpertz S, Herpertz-Dahlmann B, Zeeck A. Treatment of anorexia nervosa\u2014new evidence-based guidelines. J Clin Med. 2019;8(2):153.","journal-title":"J Clin Med"},{"key":"4604_CR15","first-page":"1","volume":"157","author":"J Yager","year":"2002","unstructured":"Yager J, Andersen A, Devlin M, Egger H, Herzog D, Mitchell J, Zerbe K. Practice guideline for the treatment of patients with eating disorders. Am Psychiatr Assoc. 2002;157:1.","journal-title":"Am Psychiatr Assoc"},{"issue":"6","key":"4604_CR16","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1037\/cou0000424","volume":"67","author":"C Fl\u00fcckiger","year":"2020","unstructured":"Fl\u00fcckiger C, Del Re A, Wlodasch D, Horvath AO, Solomonov N, Wampold BE. Assessing the alliance\u2013outcome association adjusted for patient characteristics and treatment processes: A meta-analytic summary of direct comparisons. J Couns Psychol. 2020;67(6):706.","journal-title":"J Couns Psychol"},{"key":"4604_CR17","first-page":"1","volume":"27","author":"J Werz","year":"2021","unstructured":"Werz J, Voderholzer U, Tuschen-Caffier B. Alliance matters: but how much? A systematic review on therapeutic alliance and outcome in patients with anorexia nervosa and bulimia nervosa. Eat Weight Disord-Stud Anorexia, Bulimia Obes. 2021;27:1\u201317.","journal-title":"Eat Weight Disord-Stud Anorexia, Bulimia Obes"},{"issue":"2","key":"4604_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/01.pra.0000265762.79753.88","volume":"13","author":"JE Steinglass","year":"2007","unstructured":"Steinglass JE, Eisen JL, Attia E, Mayer L, Walsh BT. Is anorexia nervosa a delusional disorder? An assessment of eating beliefs in anorexia nervosa. J Psychiatr Pract. 2007;13(2):65\u201371.","journal-title":"J Psychiatr Pract"},{"issue":"6","key":"4604_CR19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1176\/appi.ajp.2018.18101125","volume":"176","author":"E Attia","year":"2019","unstructured":"Attia E, Steinglass JE, Walsh BT, Wang Y, Wu P, Schreyer C, Kaplan AS. Olanzapine versus placebo in adult outpatients with anorexia nervosa: a randomized clinical trial. Am J Psychiatry. 2019;176(6):449\u201356.","journal-title":"Am J Psychiatry"},{"key":"4604_CR20","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1002\/brb3.2498","volume":"12","author":"R Han","year":"2022","unstructured":"Han R, Bian Q, Chen H. Effectiveness of olanzapine in the treatment of anorexia nervosa: A systematic review and meta-analysis. Brain Behav. 2022;12:2498.","journal-title":"Brain Behav"},{"issue":"1","key":"4604_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.clinthera.2020.11.006","volume":"43","author":"AF Muratore","year":"2021","unstructured":"Muratore AF, Attia E. Current therapeutic approaches to anorexia nervosa: State of the art. Clin Ther. 2021;43(1):85\u201394.","journal-title":"Clin Ther"},{"issue":"3","key":"4604_CR22","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00787-007-0670-8","volume":"17","author":"M Hrdlicka","year":"2008","unstructured":"Hrdlicka M, Beranova I, Zamecnikova R, Urbanek T. Mirtazapine in the treatment of adolescent anorexia nervosa. Eur Child Adolesc Psychiatry. 2008;17(3):187\u20139.","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"3","key":"4604_CR23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jpsychires.2004.08.001","volume":"39","author":"K Holtkamp","year":"2005","unstructured":"Holtkamp K, Konrad K, Kaiser N, Ploenes Y, Heussen N, Grzella I, Herpertz-Dahlmann B. A retrospective study of SSRI treatment in adolescent anorexia nervosa: insufficient evidence for efficacy. J Psychiatr Res. 2005;39(3):303\u201310.","journal-title":"J Psychiatr Res"},{"issue":"3","key":"4604_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.9740\/mhc.2018.05.127","volume":"8","author":"M Marvanova","year":"2018","unstructured":"Marvanova M, Gramith K. Role of antidepressants in the treatment of adults with anorexia nervosa. Mental Health Clin. 2018;8(3):127\u201337.","journal-title":"Mental Health Clin"},{"issue":"5","key":"4604_CR25","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s40263-016-0335-6","volume":"30","author":"GK Frank","year":"2016","unstructured":"Frank GK, Shott ME. The role of psychotropic medications in the management of anorexia nervosa: rationale, evidence and future prospects. CNS Drugs. 2016;30(5):419\u201342.","journal-title":"CNS Drugs"},{"issue":"1","key":"4604_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-244X-9-67","volume":"9","author":"S Fassino","year":"2009","unstructured":"Fassino S, Pier\u00f2 A, Tomba E, Abbate-Daga G. Factors associated with dropout from treatment for eating disorders: a comprehensive literature review. BMC Psychiatry. 2009;9(1):1\u20139.","journal-title":"BMC Psychiatry"},{"issue":"5","key":"4604_CR27","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/eat.20956","volume":"45","author":"H DeJong","year":"2012","unstructured":"DeJong H, Broadbent H, Schmidt U. A systematic review of dropout from treatment in outpatients with anorexia nervosa. Int J Eat Disord. 2012;45(5):635\u201347.","journal-title":"Int J Eat Disord"},{"key":"4604_CR28","doi-asserted-by":"crossref","unstructured":"Fornari V, Dancyger I. Coming of Age and Refusing to Eat: Overcoming Treatment Nonadherence for Adolescents with Anorexia Nervosa. Psychiatric Nonadherence: A Solutions-Based Approach. 2019. p. 31-42.","DOI":"10.1007\/978-3-030-12665-0_3"},{"key":"4604_CR29","unstructured":"Fairburn CG. Cognitive behavior therapy and eating disorders. Guilford Press; 2008."},{"issue":"1","key":"4604_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12888-015-0560-4","volume":"15","author":"D Novick","year":"2015","unstructured":"Novick D, Montgomery W, Treuer T, Aguado J, Kraemer S, Haro JM. Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European outpatient observational study. BMC Psychiatry. 2015;15(1):1\u20138.","journal-title":"BMC Psychiatry"},{"issue":"3","key":"4604_CR31","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.psychres.2013.01.009","volume":"209","author":"R Arbel","year":"2013","unstructured":"Arbel R, Koren D, Klein E, Latzer Y. The neurocognitive basis of insight into illness in anorexia nervosa: a pilot metacognitive study. Psychiatry Res. 2013;209(3):604\u201310.","journal-title":"Psychiatry Res"},{"issue":"4","key":"4604_CR32","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0272-7358(98)00012-9","volume":"18","author":"K Vitousek","year":"1998","unstructured":"Vitousek K, Watson S, Wilson GT. Enhancing motivation for change in treatment-resistant eating disorders. Clin Psychol Rev. 1998;18(4):391\u2013420.","journal-title":"Clin Psychol Rev"},{"key":"4604_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2019.112561","volume":"281","author":"P Gorwood","year":"2019","unstructured":"Gorwood P, Duriez P, Lengvenyte A, Guillaume S, Criquillion S. Clinical insight in anorexia nervosa: Associated and predictive factors. Psychiatry Res. 2019;281: 112561.","journal-title":"Psychiatry Res"},{"issue":"3","key":"4604_CR34","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/erv.2775","volume":"29","author":"TD Wade","year":"2021","unstructured":"Wade TD, Allen K, Crosby RD, Fursland A, Hay P, McIntosh V, Byrne S. Outpatient therapy for adult anorexia nervosa: Early weight gain trajectories and outcome. Eur Eat Disord Rev. 2021;29(3):472\u201381.","journal-title":"Eur Eat Disord Rev"},{"key":"4604_CR35","unstructured":"Cochrane Database of Systematic Reviews. Antidepressants for anorexia nervosa. 2006. https:\/\/www.cochranelibrary.com. Accessed 21 Mar 2022."},{"issue":"9","key":"4604_CR36","first-page":"378","volume":"51","author":"HE Gwirtsman","year":"1990","unstructured":"Gwirtsman HE, Guze BH, Yager J, Gainsley B. Fluoxetine treatment of anorexia nervosa: an open clinical trial. J Clin Psychiatry. 1990;51(9):378\u201382.","journal-title":"J Clin Psychiatry"},{"key":"4604_CR37","first-page":"464","volume":"52","author":"WH Kaye","year":"1991","unstructured":"Kaye WH, Weltzin TE, Hsu LG, Bulik CM. An open trial of fluoxetine in patients with anorexia nervosa. J Clin Psychiatry. 1991;52:464.","journal-title":"J Clin Psychiatry"},{"issue":"5517","key":"4604_CR38","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1136\/bmj.2.5517.793","volume":"2","author":"P Dally","year":"1966","unstructured":"Dally P, Sargant W. Treatment and outcome of anorexia nervosa. BMJ. 1966;2(5517):793.","journal-title":"BMJ"},{"issue":"3","key":"4604_CR39","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1192\/bjp.144.3.288","volume":"144","author":"W Vandereycken","year":"1984","unstructured":"Vandereycken W. Neuroleptics in the Short-Term Treatment of Anorexia Nervosa a Double-blind Placebo-Controlled Study with Sulpiride. Br J Psychiatry. 1984;144(3):288\u201392.","journal-title":"Br J Psychiatry"},{"issue":"12","key":"4604_CR40","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1176\/ajp.2006.163.12.2090","volume":"163","author":"SM Essock","year":"2006","unstructured":"Essock SM, Covell NH, Davis SM, Stroup TS, Rosenheck RA, Lieberman JA. Effectiveness of switching antipsychotic medications. Am J Psychiatry. 2006;163(12):2090\u20135.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"4604_CR41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/imj.14691","volume":"50","author":"P Hay","year":"2020","unstructured":"Hay P. Current approach to eating disorders: a clinical update. Intern Med J. 2020;50(1):24\u20139.","journal-title":"Intern Med J"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-023-04604-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-023-04604-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-023-04604-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T14:04:56Z","timestamp":1677506696000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-023-04604-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,27]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4604"],"URL":"https:\/\/doi.org\/10.1186\/s12888-023-04604-3","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,27]]},"assertion":[{"value":"16 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was approved by the ethics committee of Taichung Veterans General Hospital and conducted in accordance with Good Clinical Practice procedures and the current revision of the Helsinki Declaration. The certificate of approval was provided in related files. Because our study was a retrospective study, we applied for an informed consent waiver and it was approved by the ethics committee of Taichung Veterans General Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have no competing interests as defined by BMC, or other interests that might be perceived to influence the results and\/or discussion reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"126"}}